Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
The present invention provides an amorphous, pharmaceutically active form of a compound of formula Iwhich is substantially free of crystalline compound.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
19.11.2002
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides an amorphous, pharmaceutically active form of a compound of formula Iwhich is substantially free of crystalline compound. |
---|---|
Bibliography: | Application Number: US20010928635 |